Information Provided By:
Fly News Breaks for October 27, 2016
CELG
Oct 27, 2016 | 11:45 EDT
Piper Jaffray analyst Joshua Schimmer says he has "no complaints" following Celgene's Q3 results. The company's pipeline continues to advance, the analyst writes in a post-earnings research note. He views the recent pullback in the shares as a buying opportunity and reiterates an Overweight rating on the name with a $145 price target.
News For CELG From the Last 2 Days
There are no results for your query CELG